These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1367909)

  • 1. Development of a new culture system for human lymphokine-activated killer cells: comparison with a conventional static culture method.
    Murata M; Yano T; Yoshino I; Togami M; Sogabe M; Yasumoto K; Sugimachi K; Kimura G; Nomoto K
    Cytotechnology; 1991 Oct; 7(2):75-83. PubMed ID: 1367909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new culture system for human lymphokine-activated killer cells.
    Murata M; Yano T; Togami M; Yasumoto K; Sugimachi K; Kimura G; Nomoto K
    J Immunol Methods; 1990 May; 129(1):89-95. PubMed ID: 2338501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high density cell culture system for generation of human lymphokine-activated killer (LAK) cells for clinical use in adoptive immunotherapy.
    Shimizu K; Park K; Yamada M; Tarura K; Matsui Y; Hayakawa T
    J Clin Lab Immunol; 1990 May; 32(1):41-7. PubMed ID: 1967036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and expansion of lymphokine-activated killer cells from lymph node lymphocytes in human lung cancer.
    Yano T; Yasumoto K; Nomoto K
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):201-8. PubMed ID: 2784761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of LAK cells by high density dialyzing culture device and its cytotoxicity].
    Kohgo Y; Kanisawa Y; Sakamaki S; Nojiri S; Ueno Y; Ito Y; Niitsu Y; Hosoi S; Sato S; Urushizaki I
    Hum Cell; 1988 Mar; 1(1):54-9. PubMed ID: 3154014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of serum-free medium for the generation of lymphokine-activated killer cells.
    Togami M; Yasumoto K; Yano T; Ishida T; Kimura G; Sugimachi K; Nomoto K
    Cytotechnology; 1991 May; 6(1):39-47. PubMed ID: 1367399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of interleukin-6-enhanced lymphokine-activated killer cell function.
    Iho S; Shau HY; Golub SH
    Cell Immunol; 1991 Jun; 135(1):66-77. PubMed ID: 2018984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristic of lymphokine-activated killer cells induced from tumor draining lymph-node cell].
    Meng YG; Fu CY; Wang YZ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):535-7, 574. PubMed ID: 7835130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelatin sponge model of effector recruitment: tumoricidal activity of adherent and non-adherent lymphokine-activated killer cells after culture in interleukin-2.
    Akporiaye ET; Barbieri CA; Stewart CC; Bender JG
    J Leukoc Biol; 1991 Feb; 49(2):189-96. PubMed ID: 1991999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer and lymphokine-activated killer cell-mediated cytotoxicity in patients with oral cancer.
    Gangal SG; Tatake RJ; Krishnan N; Mukhopadhyaya R; Naik SL; Fakih AR; Rao RS
    Semin Surg Oncol; 1989; 5(5):347-50. PubMed ID: 2814145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in lectin-binding characteristics of human lymphokine-activated killer cells.
    Maruyama T; Imai Y; Harada K; Okada T; Takano M; Ikeda Y; Toda G; Oka H; Osawa T
    J Biol Response Mod; 1990 Aug; 9(4):378-86. PubMed ID: 2395003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro development of lymphocytes that function as progenitors for mucus-secreting lymphokine-activated killer (LAK) cells.
    Ginsburg H
    J Leukoc Biol; 1992 Apr; 51(4):307-15. PubMed ID: 1564395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Jhaver KG; De AK; Soman CS; Nadkarni KS
    Neoplasma; 1993; 40(1):15-20. PubMed ID: 8350943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human lymphokine-activated killer cells following brief exposure to high dose interleukin 2.
    Horton SA; Oldham RK; Yannelli JR
    Cancer Res; 1990 Mar; 50(6):1686-92. PubMed ID: 2306722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High release of tumor necrosis factor alpha, interferon gamma and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells.
    Koberda J; Bergmann L; Mitrou PS; Hoelzer D
    J Cancer Res Clin Oncol; 1991; 117(5):425-30. PubMed ID: 1909699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors.
    Beckner SK; Maluish AE; Longo DL
    Cancer Res; 1987 Oct; 47(20):5504-8. PubMed ID: 3498534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of lymphokine-activated killer cells in long-term cultures.
    Hartwig M; Körner IJ
    Immunology; 1990 Sep; 71(1):145-7. PubMed ID: 2210801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta.
    Ochoa AC; Gromo G; Alter BJ; Sondel PM; Bach FH
    J Immunol; 1987 Apr; 138(8):2728-33. PubMed ID: 2435804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
    Alderson MR; Sassenfeld HM; Widmer MB
    J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors.
    Mitchell DH; Withrow SJ; Johnston MR; Kruse CA
    Am J Vet Res; 1991 Jul; 52(7):1132-6. PubMed ID: 1892269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.